Guardant Health, Inc. (GH) earnings date

Nasdaq · Large cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 33 days, typically, give or take 9 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 5, 2026after close 36 8-K
Q2 FY2026Thu, Jul 30, 2026after close 30 8-K
Q1 FY2026Thu, May 7, 2026after close 37 8-K
Q4 FY2025Thu, Feb 19, 2026after close 50 8-K
Q3 FY2025Wed, Oct 29, 2025after close 29 8-K
Q2 FY2025Wed, Jul 30, 2025after close 30 8-K
Q1 FY2025Wed, Apr 30, 2025after close 30 8-K
Q4 FY2024Thu, Feb 20, 2025after close 51 8-K

What they guided beta

Q3 FY2026 "Document Guardant Health Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance Third quarter 2026 revenue growth of 36% driven by strong performance in Oncology and Screening Raises 2026 revenue guidance to $1.36 to $1.37 billion, representing growth of 38% to 40% PALO ALTO, Calif." exhibit
Q3 FY2026 "Cash, cash equivalents, and restricted cash were $1.1 billion as of September 30, 2026. 2026 Guidance Guardant Health now expects full year 2026 revenue to be in the range of $1.36 to $1.37 billion, representing growth of 38% to 40% compared to full year 2025." exhibit
Read from the sentence: revenue $1.36 billion to $1.37 billion, FY2026
Q3 FY2026 "Guardant Health now expects full year 2026 non-GAAP gross margin to be 65%, compared to prior guidance of 64% to 65%." exhibit
Q3 FY2026 "Guardant Health now expects full-year free cash flow burn of $205 million to $220 million, compared to the previous outlook of $195 million to $205 million." exhibit
Q2 FY2026 "Document Guardant Health Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance Second quarter 2026 revenue growth of 44% driven by strong performance in Oncology and Screening Raises 2026 revenue guidance to $1.34 to $1.36 billion, representing growth of 36% to 38% PALO ALTO, Calif." exhibit
Q2 FY2026 "Cash, cash equivalents, and restricted cash were $1.2 billion as of June 30, 2026. 2026 Guidance Guardant Health now expects full year 2026 revenue to be in the range of $1.34 to $1.36 billion, representing growth of 36% to 38% compared to full year 2025." exhibit
Read from the sentence: revenue $1.34 billion to $1.36 billion, FY2026
Q2 FY2026 "Oncology revenue is now expected to grow approximately 30% in 2026, compared to prior guidance of 28% to 29%." exhibit
Q2 FY2026 "Oncology volume is now expected to grow to approximately 50% in 2026, compared to prior guidance of approximately 35%." exhibit
Q2 FY2026 "Guardant Health continues to expect full year 2026 non-GAAP gross margin to be in the range of 64% to 65%." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/GH
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/GH

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

GH earnings date badge

HTML

<a href="https://veritasdata.dev/company/GH/"><img src="https://veritasdata.dev/embed/GH.svg" alt="GH earnings date" width="240" height="56"></a>

Markdown

[![GH earnings date](https://veritasdata.dev/embed/GH.svg)](https://veritasdata.dev/company/GH/)

Script

<script async src="https://veritasdata.dev/embed/GH.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/GH"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.